Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Countervailing effects of rapamycin (sirolimus) on nuclear factor-κB activities in neointimal and medial smooth muscle cells — Wolfgang Dichtl (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Countervailing effects of rapamycin (sirolimus) on nuclear factor-κB activities in neointimal and medial smooth muscle cells
Shared by
Jozef Dulak
Jagiellonian University Cracow
Countervailing effects of rapamycin (sirolimus) on nuclear factor-κB activities in neointimal and medial smooth muscle cells
Article
2005
en
Authors
+7 more
WD
Wolfgang Dichtl
ES
Eva-Maria Stocker
KM
Klaudia Mistlberger
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
Effect of dexamethasone on interleukin‐1β‐(IL‐1β)‐induced nuclear factor‐κB (NF‐κB) and κB‐dependent transcription in epithelial cells
Robert Newton
,
Lorraine Hart
,
David A. Stevens
,
Martin Bergmann
,
Louise Donnelly
,
Ian M. Adcock
,
Peter J Barnes
Article
2003
Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages.
Alicja Józkowicz
,
Jozef Dulak
Article
1993
β-adrenoceptors on smooth muscle, nerves and inflammatory cells
Peter J Barnes
Article
2006
Nuclear factor-κB in cancer development and progression
Michael Karin
Article
2004
Nuclear factor‐κB does not mediate the inhibitory effects of dexamethasone on granulocyte–macrophage colony‐stimulating factor expression
Martin Bergmann
,
Karl J. Staples
,
Peter J Barnes
,
Robert Newton
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.